Page last updated: 2024-08-17

nad and MPTP Neurotoxicity Syndrome

nad has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acuña-Castroviejo, D; Camacho, E; Carrión, MD; Doerrier, C; Escames, G; Espinosa, A; López, LC; Mora, F; Tapias, V	1

Other Studies

1 other study(ies) available for nad and MPTP Neurotoxicity Syndrome

Article	Year
Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Brain research bulletin, 2011, May-30, Volume: 85, Issue:3-4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Cytosol; Disease Models, Animal; Drug Administration Schedule; Kynurenine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria; MPTP Poisoning; NAD; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Oxidation-Reduction; Substantia Nigra	2011

Article

Year

Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.

Brain research bulletin, 2011, May-30, Volume: 85, Issue:3-4

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Cytosol; Disease Models, Animal; Drug Administration Schedule; Kynurenine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria; MPTP Poisoning; NAD; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Oxidation-Reduction; Substantia Nigra

2011